Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
Subscribe To Our Newsletter & Stay Updated
